Keywords: elan/wyeth, pull, high, dose, ad, drug, major

Elan/Wyeth pull high dose of AD drug

Article | 03 April 2009

Print This

US drug major Wyeth and Ireland's Elan will discontinue the highest dosing regimen of bapineuzumab in two ongoing Phase III ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in